Trial record 1 of 1 for:    efc11319
Previous Study | Return to List | Next Study

Evaluation of Cardiovascular Outcomes in Patients With Type 2 Diabetes After Acute Coronary Syndrome During Treatment With AVE0010 (Lixisenatide) (ELIXA)

This study has been completed.
Information provided by (Responsible Party):
Sanofi Identifier:
First received: June 17, 2010
Last updated: November 12, 2015
Last verified: November 2015